The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Krishnankutty Sudhir

Showing 1-14 of 14 articles
Coronary interventions
One-year clinical outcomes of patients treated with everolimus-eluting bioresorbable vascular scaffolds versus everolimus-eluting metallic stents: a propensity score comparison of patients enrolled in the ABSORB EXTEND and SPIRIT trials
Costa Jr J, Abizaid A, Bartorelli A, Whitbourn R, Jepson N, Perin M, Steinwender C, Stuteville M, Ediebah D, Sudhir K, Serruys P
November 20, 2016 | 10.4244/EIJV12I10A206
The ABSORB EXTEND study: preliminary report of the twelve-month clinical outcomes in the first 512 patients enrolled
Abizaid A, Costa Jr J, Bartorelli A, Whitbourn R, van Geuns R, Chevalier B, Patel T, Seth A, Stuteville M, Dorange C, Cheong W-F, Sudhir K, Serruys P
April 20, 2015 | 10.4244/EIJV10I12A243
Incidence, time course and predictors of early vs. late target lesion revascularisation after everolimus-eluting stent implantation: a SPIRIT V substudy
Niccoli G, Stuteville M, Sudhir K, Li D, Montone R, Bolognese L, Grube E
July 26, 2013 | 10.4244/EIJV9I3A57
Comparison of vascular response to the everolimus-eluting stent versus the paclitaxel-eluting stent: intravascular ultrasound results from the SPIRIT III trial
Yamasaki M, Tsujino I, Lima-Filho M, Ako J, Shimohama T, Hasegawa T, Sakurai R, Sudhir K, Stone G, Waseda K, Honda Y, Fitzgerald P
October 26, 2012 | 10.4244/EIJV8I6A112
Stent thrombosis: insights on outcomes, predictors and impact of dual antiplatelet therapy interruption from the SPIRIT II, SPIRIT III, SPIRIT IV and COMPARE trials
Kedhi E, Stone G, Kereiakes D, Serruys P, Parise H, Fahy M, Simonton C, Sudhir K, Sood P, Smits P
September 28, 2012 | 10.4244/EIJV8I5A92
SPIRIT Women, evaluation of the safety and efficacy of the XIENCE V everolimus-eluting stent system in female patients: referral time for coronary intervention and 2-year clinical outcomes
Morice M, Mikhail G, Mauri i Ferr F, Modena M, Strasser R, Grinfeld L, Sudhir K, Stuteville M, Papeleu P, Li D, Rutledge D, Windecker S
July 27, 2012 | 10.4244/EIJV8I3A51
Impact of age on clinical outcomes after everolimus-eluting and paclitaxel-eluting stent implantation: pooled analysis from the SPIRIT III and SPIRIT IV clinical trials
Hermiller J, Sudhir K, Applegate R, Rizvi A, Wang J, Gordon P, Yaqub M, Cao S, Ferguson J, Smith R, Sood P, MPhil M, Stone G
May 15, 2012 | 10.4244/EIJV8I1A14
Predictors of early and late outcomes after everolimus and paclitaxel-eluting coronary stents
Applegate R, Hermiller J, Gordon P, Yaqub M, Sood P, Su X, Cao S, Sudhir K, Stone G
January 20, 2012 | 10.4244/EIJV7I9A165
Clinical and angiographic outcomes of elderly patients treated with everolimus-eluting versus paclitaxel-eluting stents: three-year results from the SPIRIT III randomised trial
Hermiller J, Nikolsky E, Lansky A, Applegate R, Sanz M, Yaqub M, Sood P, Cao S, Sudhir K, Stone G
July 29, 2011 | 10.4244/EIJV7I3A54
Comparison between the first and second generation bioresorbable vascular scaffolds: a six month virtual histology study
Brugaletta S, Garcia-Garcia H, Diletti R, Gomez-Lara J, Garg S, Onuma Y, Shin E, van Geuns R, De Bruyne B, Dudek D, Thuesen L, Chevalier B, McClean D, Windecker S, Whitbourn R, Dorange C, Veldhof S, Rapoza R, Sudhir K, Bruining N, Ormiston J, Serruys P
April 20, 2011
Side branch occlusion with everolimus-eluting and paclitaxel-eluting stents: three-year results from the SPIRIT III randomised trial
Lansky A, Yaqub M, Hermiller J, Smith R, Farhat N, Caputo R, Williams J, Sanz M, Koo K, Sood P, Sudhir K, Stone G
January 11, 2011
Comparison of everolimus-eluting and paclitaxel-eluting coronary stents in patients with two treated vessels: 2-year results from the SPIRIT III randomised trial
Applegate R, Hermiller J, Sanz M, Doostzadeh J, Pierson W, Su X, Lansky A, Sudhir K, Stone G
September 30, 2010
In vivo evaluation of stent strut distribution patterns in the bioabsorbable everolimus-eluting device: an OCT ad hoc analysis of the revision 1.0 and revision 1.1 stent design in the ABSORB clinical trial
Okamura T, Garg S, Gutiérrez-Chico J-L, Shin E, Onuma Y, Garcia-Garcia H, Rapoza R, Sudhir K, Regar E, Serruys P
April 12, 2010
A pooled gender based analysis comparing the XIENCE V® everolimus-eluting stent and the TAXUS paclitaxel-eluting stent in male and female patients with coronary artery disease, results of the SPIRIT II and SPIRIT III studies: two-year analysis
Seth A, Serruys P, Lansky A, Hermiller J, Onuma Y, Miquel-Hebert K, Yu S, Veldhof S, Sood P, Sudhir K, Stone G
February 25, 2010

Latest news

NEW ISSUE
State of the Art on ViV-TAVI; Transseptal Punctures; Endovascular Closure and TF-TAVI; Percutaneous PVL Closure: Long-Term Outcomes; and more
October 20, 2021
STATE OF THE ART
Valve-in-valve TAVI: a practical overview
Giuseppe Tarantini et al.
October 20, 2021
AHEAD OF PRINT
Impact of LVOT calcification in transfemoral TAVI patients
L. Waldschmidt et al.
October 19, 2021
AHEAD OF PRINT
Serum caffeine causes adenosine-induced FFR overestimation
Hideaki Tanaka et al.
October 15, 2021
VIEWPOINT
My Stroke Story
Marco Noc
October 20, 2021
EDITORIAL
Transcatheter Paravalvular Leak Closure: Catch Me If You Can
Thomas Pilgrim et al.
October 20, 2021
STATE OF THE ART
Glucose-Lowering Therapy in Patients undergoing Percutaneous Coronary Intervention
Isabelle Johansson et al.
October 1, 2021
Coronary
Valvular disease
Heart failure
Peripheral
Hypertension
Stroke